Because IFN is akey pathogenic determinant for lupus [3,26–28],the potentiation of B lymphocytes for IFN production might be related to the failureof the lupus treatment with the antibody [20–23]. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.